Table 1.
Celecoxib Dose | ||
200 mg twice daily | 400 mg twice daily | |
NAF (plasma) | NAF(plasma) | |
Samples | 19 (20) | 22 (260 |
Age (years) | ||
Median | 48 (47) | 50.5 (50.5) |
Range | 23–68 (23–68) | 30–81 (30–81) |
Premenopausal | 5 (6) | 11 (11) |
Race | ||
White | 19 (20) | 40 (45) |
Black | 0 | 0 |
Asian | 0 | 0 |
American Indian | 0 | 1 (1) |
Primary Risk Factors for Enrollment | ||
Family History | 11 (11) | 14 (17) |
Hyperplasia with/without atypia | 3 (3) | 6 (6) |
History of Breast Cancer | 3 (3) | 3 (3) |
History Prior Breast Biopsy | 2 (3) | 0 |